Honeywell Announces Filing of Form 10 Registration Statement and Upcoming Investor Day for Planned Spin-Off of Solstice Advanced Materials
- Solstice Advanced Materials will be a pure-play specialty materials company with leading market positions in refrigerants, semiconductor materials, protective fibers, and healthcare packaging solutions
- Filing marks latest milestone as Solstice prepares to become a standalone public company in the fourth quarter of 2025
-
Investor Day scheduled for
October 8, 2025 , inNew York City to provide details on Solstice's business and value creation strategy
"This Form 10 filing marks a pivotal step toward the exciting launch of Solstice Advanced Materials as an innovation-led independent company. With
"Today is a milestone that underscores Solstice's tremendous momentum as we prepare for our next chapter as a public company," said
Highlights from the Form 10
The Form 10 introduces Solstice Advanced Materials, which will be:
-
A differentiated advanced materials company that is a leading global provider of refrigerants, semiconductor materials, protective fibers, and healthcare packaging, and generated net sales of
$3.8 billion , net income of$0.6 billion 1, and adjusted EBITDA2 of$1.1 billion 1 in 2024; - Home to well-known brands, such as Solstice®, Genetron®, Aclar®, Spectra®, Fluka®, and Hydranal®, supported by more than 3,900 employees, 21 manufacturing sites, and four R&D sites; and
- Built to create value for stakeholders by partnering with its customers to capitalize on secular growth trends, making targeted investments into innovation and manufacturing capabilities while maintaining a strong balance sheet, and supporting resilient, industry-leading margins through disciplined use of the Solstice Accelerator operating model.
Solstice Advanced Materials will be organized into two operating segments:
-
Refrigerants & Applied Solutions ("RAS"): A leading portfolio of low-global-warming-potential (LGWP) refrigerants, blowing agents, solvents, and aerosol materials, distributed and sold through the Solstice®, Genetron®, and Aclar® brands. This segment generated net sales of
$2.7 billion in 2024. -
Electronic &
Specialty Materials ("ESM"): A leading portfolio of electronic materials, industrial-grade fibers, laboratory life sciences materials, and specialty chemicals, distributed and sold through the Spectra®, Fluka®, and Hydranal® brands. This segment generated net sales of$1.0 billion in 2024.
Solstice Investor Day
Solstice will host an Investor Day during the afternoon of
The event will also highlight Solstice's differentiated product portfolio, including Solstice® low-global-warming-potential refrigerants, Spectra® high-performance fibers, Hydranal® analytical reagents, and Aclar® pharmaceutical packaging solutions.
A live webcast of the event, along with related presentation materials, will be available through the Investor Relations section of
Additional Information
Solstice's common stock is expected to be listed on the
About
Additional Information
Forward-looking Statements
We describe many of the trends and other factors that drive our business and future results in this release. Such discussions contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are those that address activities, events, or developments that management intends, expects, projects, believes, or anticipates will or may occur in the future. They are based on management's assumptions and assessments in light of past experience and trends, current economic and industry conditions, expected future developments, and other relevant factors, many of which are difficult to predict and outside of our control. They are not guarantees of future performance, and actual results, developments and business decisions may differ significantly from those envisaged by our forward-looking statements. We do not undertake to update or revise any of our forward-looking statements, except as required by applicable securities law. Our forward-looking statements are also subject to material risks and uncertainties, including ongoing macroeconomic and geopolitical risks, such as changes in or application of trade and tax laws and policies, including the impacts of tariffs and other trade barriers and restrictions, lower GDP growth or recession in the
This release contains Adjusted EBITDA, a financial measure presented on a non-GAAP basis.
Management believes that, when considered together with reported amounts, this measure is useful to investors and management in understanding Solstice Advanced Materials' ongoing operations and in the analysis of ongoing operating trends. This measure should be considered in addition to, and not as a replacement for, the most comparable GAAP measure. Refer to the Appendix attached to this release for a reconciliation of the non-GAAP financial measure to the most directly comparable GAAP measure.
Appendix
Non-GAAP Financial Measure
The following information provides the definition and reconciliation of the non-GAAP financial measure presented in this press release to which this reconciliation is attached to the most directly comparable financial measure calculated and presented in accordance with generally accepted accounting principles (GAAP).
Management believes that, when considered together with reported amounts, this measure is useful to investors and management in understanding Solstice Advanced Materials' ongoing operations and in the analysis of ongoing operating trends. This measure should be considered in addition to, and not as a replacement for, the most comparable GAAP measure. Other companies may calculate this non-GAAP measure differently, limiting the usefulness of this measure for comparative purposes.
Management does not consider this non-GAAP measure in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitations of this non-GAAP financial measure is that it excludes significant expenses and income that are required by GAAP to be recognized in the combined financial statements. In addition, it is subject to inherent limitations as it reflects the exercise of judgments by management about which expenses and income are excluded or included in determining this non-GAAP financial measure. Investors are urged to review the reconciliation of the non-GAAP financial measure to the comparable GAAP financial measures and not to rely on any single financial measure to evaluate Solstice Advanced Materials' business.
Solstice Advanced Materials |
|||
Reconciliation of Net Income to Adjusted EBITDA |
|||
(Unaudited) |
|||
(Dollars in millions) |
|||
|
|||
|
Year Ended
|
||
Net income |
$ 605 |
||
Income tax expense |
192 |
||
Depreciation |
175 |
||
Amortization |
42 |
||
Interest and other financial charges |
13 |
||
Other expense1 |
34 |
||
Stock compensation expense |
17 |
||
Other non-recurring items2 |
10 |
||
Asset retirement obligation accretion |
2 |
||
Transaction costs |
4 |
||
Pension and other postretirement expense |
2 |
||
Repositioning charges |
2 |
||
Adjusted EBITDA |
$ 1,098 |
||
1 Represents Other expense excluding Equity income of affiliated companies, which is included in Adjusted EBITDA. |
|||
2 Including but not limited to impairment charges, litigation and insurance settlements, and gains and losses on disposal of assets. |
We define adjusted EBITDA as net income excluding income taxes, depreciation, amortization, interest and other financial charges, other expense, stock compensation expense, pension and other postretirement income (expense), transaction-related costs, repositioning charges, asset retirement obligation accretion, and certain other items that are otherwise of an unusual or non-recurring nature (including but not limited to impairment charges, litigation and insurance settlements, and gains and losses on disposal of assets). We believe this measure is useful to investors as it provides greater transparency with respect to supplemental information used by management in its financial and operational decision making, as well as understanding ongoing operating trends.
_______________ |
|
1 |
Net income and adjusted EBITDA in 2024 exclude standalone and public company costs of |
2 |
See additional information at the end of this release regarding this non-GAAP financial measure. |
Contacts: |
|
Media |
Investor Relations |
Stacey Jones |
Sean Meakim |
(980) 378-6258 |
(704) 627-6200 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/honeywell-announces-filing-of-form-10-registration-statement-and-upcoming-investor-day-for-planned-spin-off-of-solstice-advanced-materials-302536230.html
SOURCE